Like most, my thoughts are all over the map with Bs value. But from what I’ve read, IMO, the uses could range from the obvious in current trials to other levels outside the body. Using nanotech to use B embedded on medical instruments and just about anything in an operating room to prevent infection from the outside...infection is such a huge side effect in every procedure...the platform may have nearly endless potential. May very well be part of the reason a deal isn’t done yet. Nailing down the value may be extremely difficult. As I am not as well versed as I would like to be, would anyone be able to tell the board if B can be licensed to different entities for uses specific to that entities needs ONLY, and them licensed to another for that entities needs?